Wow! Already, illuminate '09 has been such a whirlwind of activity. We thoroughly enjoyed spending time with so many of our distributors at the Opening Party and Disney World®. It's always so wonderful to renew friendships with people we haven't seen in a while, and begin relationships with new friends from all over the world.
We promised that there would be big things in store at illuminate '09 and General Session I definitely did not disappoint. We're so pleased to announce the results of our latest 4Life Transfer Factor® findings—showing that 4Life Transfer Factor Tri-Factor® Formula increased production of IgA antibodies by an average of 73%, in 100% of all participants¹! Since IgA antibodies provide a vital barrier of protection for our bodies, these new results suggest another significant way in which 4Life Transfer Factor products can support a strong and smart immune system, and a healthy and fulfilling life.
Also during General Session I, we introduced a brand-new product, 4Life Transfer Factor RioVida® Burst. It has all the goodness (and great taste!) of 4Life Transfer Factor RioVida Tri-Factor Formula, and now it's even more convenient and portable!
We're so proud to be involved with the fine scientists in our Research and Development department, who are constantly making sure that we provide our distributors with high-quality, innovative, and effective products that are backed in solid science. We're confident that our new products and this new scientific insight will enable you to further support your health, and go further with your 4Life business.
For more information on the details of the new 4Life Transfer Factor test and all of our new products, please visit www.4life.com.
¹Immunoglobulin A (IgA) test results obtained from an initial, open-label study on 21 reportedly healthy adults. Participants took 4Life Transfer Factor Tri-Factor Formula for two weeks, followed by 4Life Transfer Factor RioVida Tri-Factor Formula. One hundred percent of participants saw an increase in the production rate of salivary secretory IgA by an average of 73% after taking 4Life Transfer Factor products for four weeks when compared to a one-week baseline; a brief drop occurred at the transition between the two products.
Posts
